VYxeoS Liposomal Italian Observational Study iN the Real Practice

NCT06143839 · clinicaltrials.gov ↗

COMPLETED

Status

113

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Myeloid Leukemia (AML)
Acute Myeloid Leukemia With Myelodysplasia-Related Changes
Therapy-Related Acute Myeloid Leukemia

Interventions

DRUG: Vyxeos liposomal

Sponsor

Jazz Pharmaceuticals

Collaborators

[object Object]